Compared to healthy donors, HNSCC-derived exosomes contained higher levels of immune checkpoint molecules (TIM-3, PD-L1) and tumor-associated markers (CD44v3, CD39). This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.